NCT01779960

Brief Summary

Up to this moment, the majority of studies assessing the level of physical activity in daily life in patients with COPD are limited to a cross-sectional design, which does not take into account natural variation of physical activity in daily life due to differences in climatic conditions faced throughout the year. Preliminary evidences suggest that patients with COPD have different physical activity levels according to the seasons of the year. However, the limited current evidences do not allow us to know the magnitude of differences in the level of daily physical activity in patients with COPD when taking into account climatic changes resulting from different seasons of the year in cities and countries with contrasting climatic conditions. This gap observed in the literature does not allow us at this moment to know whether we should or not consider the season of the year as one of the main causes of variability while assessing physical activity in daily life in patients with COPD. The present project proposes to investigate the hypothesis that patients with COPD who live in a place with less marked decrease in temperature between summer and winter (Londrina, Brazil) have less variability in the level of physical activity in daily life through the year in comparison to patients who live in a place with more marked climatic variability during these seasons (Leuven, Belgium).

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2013

Typical duration for all trials

Geographic Reach
2 countries

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

January 28, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 30, 2013

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

June 11, 2015

Status Verified

June 1, 2015

Enrollment Period

2.6 years

First QC Date

January 28, 2013

Last Update Submit

June 9, 2015

Conditions

Keywords

Pulmonary Disease, Chronic ObstructiveMotor activityClimatologic station

Outcome Measures

Primary Outcomes (1)

  • Physical activity in daily life

    Two activity monitors (the SenseWear armband and the Fitbit) will be simultaneously worn during 7 consecutive days. The SenseWear armband (BodyMedia, Pittsburg, PA, USA) is a multisensor composed by a biaxial accelerometer and physiologic sensors. It is a small (8.8 x 5.6 x 2 cm) and lightweight (82g) monitor that was already validated for energy expenditure estimation in patients with COPD. The Fitbit (Fitbit, Inc., San Francisco, CA, USA) is a recently released triaxial accelerometer that is smaller (3.6 x 2.9 x 1 cm) and more lightweight (8g) than the SenseWear. This device provides the number of steps, the distance walked and the energy expenditure in calories, among other variables. In the 7 days of assessment, the patient will remain with the device during 24 hours/day. The patients will be strictly instructed to avoid changing their daily physical activity habits during the monitoring period.

    January 2013 and July 2013. Participants will be followed for the duration of 6 months.

Secondary Outcomes (3)

  • Six minute walking test

    January 2013 and July 2013. Participants will be followed for the duration of 6 months.

  • Spirometry

    January 2013 and July 2013. Participants will be followed for the duration of 6 months.

  • Chronic Respiratory Disease Questionnaire (CRQ)

    January 2013 and July 2013. Participants will be followed for the duration of 6 months.

Study Arms (2)

Londrina

20 patients with moderate-severe COPD from State University of Londrina, Brazi

Other: Londrina

Leuven

20 patients with moderate-severe COPD from Catholic University of Leuven, Belgium

Other: Leuven

Interventions

Two groups of patients, one group in Londrina and another group in Leuven, will be simultaneously and objectively evaluated concerning their physical activity in daily life during one week in two different moments: in January 2013 (winter in Leuven and summer in Londrina), and then the same two groups of patients will be once again simultaneously re-evaluated during another week in July 2013 (summer in Leuven and winter in Londrina).

Also known as: Climatologic Station
Londrina
LeuvenOTHER

Two groups of patients, one group in Londrina and another group in Leuven, will be simultaneously and objectively evaluated concerning their physical activity in daily life during one week in two different moments: in January 2013 (winter in Leuven and summer in Londrina), and then the same two groups of patients will be once again simultaneously re-evaluated during another week in July 2013 (summer in Leuven and winter in Londrina).

Also known as: Climatologic Station
Leuven

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The sample will be composed by at least 35 patients with moderate-severe COPD from each institution involved (Catholic University of Leuven, Belgium and State University of Londrina, Brazil), adding up to 70 patients. However, the sample size could be increased if necessary to achieve intermediate calculation of the sample power performed during the study. Both groups should be similar concerning anthropometric characteristics, gender distribution and severity feature of the disease (especially FEV1). Therefore, an eventual increase in the final number of patients may also be necessary in case this similarity is not achieved in the final data collection of the planned sample.

You may qualify if:

  • Diagnosis of COPD based on internationally accepted criteria
  • Absence of orthopedic comorbidities which could interfere on the performance of the proposed assessments

You may not qualify if:

  • Patients will be excluded of the study if they do not demonstrate physical or cognitive conditions to complete the proposed assessments,
  • If they suffer from a moderate or severe acute exacerbation in the period between the two assessment points
  • If they decide to leave the study for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium

Leuven, Belgium

RECRUITING

University Hospital Londrina , Universidade Estadual de Londrina, Brasil

Londrina, Paraná, Brazil

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Fabio Pitta, PhD

    Laboratory of Research in Respiratory Physiotherapy, State University of Londrina, Brazil

    STUDY CHAIR
  • Karina C. Furlanetto, PT

    Laboratory of Research in Respiratory Physiotherapy, State University of Londrina, Brazil

    STUDY DIRECTOR
  • Nidia A. Hernandes, PhD

    Laboratory of Research in Respiratory Physiotherapy, State University of Londrina, Brazil

    PRINCIPAL INVESTIGATOR
  • Thais Sant'Anna, MSc

    Laboratory of Research in Respiratory Physiotherapy, State University of Londrina, Brazil

    PRINCIPAL INVESTIGATOR
  • Vanessa S. Probst, PhD

    Laboratory of Research in Respiratory Physiotherapy, State University of Londrina, Brazil

    PRINCIPAL INVESTIGATOR
  • Thierry Troosters, PhD

    University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium

    STUDY CHAIR
  • Heleen Demeyer, PT

    University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium

    STUDY DIRECTOR
  • Carlos A. Camillo, MSc

    University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium

    PRINCIPAL INVESTIGATOR
  • Miek Hornickx, PT

    University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karina Furlanetto, PT

CONTACT

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Fabio Pitta

Study Record Dates

First Submitted

January 28, 2013

First Posted

January 30, 2013

Study Start

January 1, 2013

Primary Completion

August 1, 2015

Study Completion

November 1, 2015

Last Updated

June 11, 2015

Record last verified: 2015-06

Locations